AndersonPO, ValdesV. Variation of milk intake over time: Clinical and pharmacokinetic implications. Breastfeed Med, 2015; 10:142–144.
2.
BeggEJ, DuffullSB, HackettLP, et al.Studying drugs in milk: Time to unify the approach. J Hum Lact, 2002; 18:323–332.
3.
BennettPN, ed. Drugs and Human Lactation, 1st ed. Amsterdam: Elsevier, 1988, p. 29.
4.
AtkinsonHC, BeggEJ, DarlowBA. Drugs in human milk: Clinical pharmacokinetic considerations. Clin Pharmacokinet, 1988; 14:217–240.
5.
AndersonPO, ManoguerraAS, ValdesV. A review of adverse reactions in infants from medications in breastmilk. Clin Pediatr (Phila), 2016; 55:236–244.
6.
SoussanC, GouraudA, PortolanG, et al.Drug-induced adverse reactions via breastfeeding: A descriptive study in the French Pharmacovigilance Database. Eur J Clin Pharmacol, 2014; 70:1361–1366.
7.
BennettPN, NotarianniLJ. Risk from drugs in breast milk: An analysis by relative dose. Br J Clin Pharmacol, 1996; 42:P673–P674. Abstract.
8.
SachsHC, The Committee on Drugs. The transfer of drugs and therapeutics into human breast milk: An update on selected topics. Pediatrics, 2013; 132:e796–e809.
OrsoliniL, BellantuonoC. Serotonin reuptake inhibitors and breastfeeding: A systematic review. Hum Psychopharmacol, 2015; 30:4–20.
11.
PinheiroE, BogenDL, HoxhaD, et al.Sertraline and breastfeeding: Review and meta-analysis. Arch Womens Ment Health, 2015; 18:139–146.
12.
WeisskopfE, FischerCJ, Bickle GrazM, et al.Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence. Expert Opin Drug Saf, 2015; 14:413–427.
13.
SriramanNK, MelvinK, Meltzer-BrodyS. ABM Clinical Protocol #18: Use of antidepressants in breastfeeding mothers. Breastfeed Med, 2015; 10:290–299.
14.
MeadorKJ, BakerGA, BrowningN, et al.Breastfeeding in children of women taking antiepileptic drugs: Cognitive outcomes at age 6 years. JAMA Pediatr, 2014; 168:729–736.
